Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/1409012/000119312508071377/d10k.htm
October 2010
July 2010
June 2010
May 2010
March 2010
February 2010
January 2010
December 2009
November 2009
August 2009
Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/1409012/000119312508071377/d10k.htm
Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Abraxis Bioscience, Inc..
Abraxis Bioscience, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2008 10-K Annual Report includes:
Material Contracts, Statements, Certifications & more
Abraxis Bioscience, Inc. provided additional information to their SEC Filing as exhibits
CIK: 1409012
Form Type: 10-K Annual Report
Accession Number: 0001193125-08-071377
Submitted to the SEC: Mon Mar 31 2008 5:23:57 PM EST
Accepted by the SEC: Mon Mar 31 2008
Period: Monday, December 31, 2007
Industry: Pharmaceutical Preparations